MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
The launch coincides with IBS Awareness Month in April
The launch coincides with IBS Awareness Month in April
PMDA is regarded among the most stringent regulatory bodies globally
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
The trial also demonstrated significant improvements across multiple secondary endpoints
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Subscribe To Our Newsletter & Stay Updated